Pharmacotherapy for multidrug resistant tuberculosis

ABSTRACT

The current global concern in the treatment of tuberculosis (TB) is the emergence of resistance to the two most potent drugs namely, isoniazid and rifampicin. Emergence of multidrug resistance tuberculosis (MDR- TB) is now a health problem faced by most of the developing countries as well as developed countries across the globe. MDR-TB is a man-made disease that is caused by improper treatment, inadequate drug supplies, and poor patient supervision. HIV infection and AIDS have been implicated as important cause for this. The review of a published literature suggests that the most powerful predictor of treatment of MDR-TB is a history of treatment of TB. Although the treatment is efficacious, there are also a number of adverse effects caused by drugs used in the treatment of MDR-TB.

KEYWORDS

• Cycloserine
• ethionamide
• kanamycin
• multidrug resistance tuberculosis
• para-aminosalicylic acid

Showing references and in-text citations exactly as published.

• DOI10.4103/0976-500X.95502Copy

RELATED ARTICLES

Matched on section and article type within this issue of JPP.

• Article · VOLUME 3, ISSUE 2Measurement of invasive blood pressure in ratsSubramani Parasuraman, Ramasamy Raveendran · pp. 87–93Same type: Article
• Article · VOLUME 3, ISSUE 2A review of antihistamines used during pregnancySumit Kar, Ajay Krishnan, Preetha K., Atul Mohankar · pp. 105–108Same type: Article
• Article · VOLUME 3, ISSUE 2Ulipristal acetate, a progesterone receptor modulator for emergency contraceptionShilpa P. Jadav, Dinesh M. Parmar · pp. 109–111Same type: Article
• Article · VOLUME 3, ISSUE 2Effect of rolipram, a phosphodiesterase enzyme type– 4 inhibitor, on γ-amino butyric acid content of the frontal cortex in mice exposed to chronic mild stressAmany Mohamed Shalaby, Sahar Mohamed Kamal · pp. 132–137Same type: Article